Combined calcium and vitamin D supplementation is not superior to calcium supplementation alone in improving disturbed bone metabolism in patients with congestive heart failure

European Journal of Clinical Nutrition

Volumn 62, Issue 12, 2008, Pages 1388-1394

  Schleithoff, S S ^a,b   Zittermann, A ^b   Tenderich, G ^b   Berthold, H K ^c   Stehle, P ^a   Koerfer, R ^b  

^a UNIVERSITY OF BONN   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c Drug Commission of the German Medical Association   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALDOSTERONE ANTAGONIST; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CARBONATE; CARBOXY TERMINAL TELOPEPTIDE; COLECALCIFEROL; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; MAGNESIUM; NITRATE; OSTEOCALCIN; PARATHYROID HORMONE; PLACEBO; POTASSIUM; THIAZIDE DIURETIC AGENT;

ADULT; ARTICLE; BONE METABOLISM; BONE TURNOVER; CALCIUM INTAKE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FOLLOW UP; FRAGILITY FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; VITAMIN BLOOD LEVEL; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

BIOLOGICAL MARKERS; BONE AND BONES; BONE RESORPTION; CALCIUM; CALCIUM, DIETARY; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; DRUG SYNERGISM; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; OSTEOCALCIN; PARATHYROID HORMONE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 57449084339     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1602861     Document Type: Article

References (36)

1. Albanese MC, Plewka M, Gregori D, Fresco C, Avon G, Calandro D et al. (1999). Use of medical resources and quality of life of patients with chronic heart failure: A prospective survey in a large Italian community hospital. Eur J Heart Fail 1, 411-417.
2. Barger-Lux MJ, Heaney RP, Lanspa SJ, Healy JC, DeLuca HF (1995). An investigation of variation in calcium absorption efficiency. J Clin Endocrinol Metab 80, 406-411.
3. Bischoff-Ferrari HA, Giovannucci E, Willettt WC, Dietrich T, Dawson-Hughes B (2006). Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84, 18-28.
4. Blansfield HN, Andrew CB (2000). Osteoporosis: A factor in mortality following cardiac surgery. Conn Med 64, 71-73.
5. Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S et al. (1992). Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 327, 1637-1642.
6. Chapuy MC, Pamphile R, Paris E, Kempf C, Schlichting M, Arnaud S et al. (2002). Combined calcium and vitamin D3 supplementation in elderly women: Confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: The Decalyos II study. Osteoporos Int 13 257-264.
7. Christ E, Linka A, Junga G, Odermatt M, Steinert H, Kiowski W et al. (1996). Bone density and laboratory parameters of bone metabolism in patients with terminal heart disease. Schweiz Med Wochenschr 126, 1553-1559.
8. Dawson-Hughes B, Harris S, Krall EA, Dallal GE (1997). Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 337, 670-676.
9. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R (2005). Estimates of optimal vitamin D status. Osteoporos Int 16, 713-716.
10. Devine A, Wilson SG, Dick IM, Prince RL (2002). Effects of vitamin D metabolites on intestinal calcium absorption and bone turnover in elderly women. Am J Clin Nutr 75, 283-288.
11. Ervin RB, Kennedy-Stephenson J (2002). Mineral intakes of elderly adult supplement and non-supplement users in the third national health and nutrition examination survey. J Nutr 32, 3422-3427.
12. Glerup H, Mikkelsen K, Poulsen L, Hass E, Overbeck S, Thomsen J et al. (2000). Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited. J Intern Med 247 260-268.
13. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ (2003a). Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 77, 204-210.
14. Heaney RP, Dowell MS, Hale CA, Bendich A (2003b). Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 22, 142-146.
15. Kamel S, Fardellone P, Meddah B, Lorget-Gondelmann F, Sebert JL, Brazier M (1998). Clin Chem 44, 1437-1442.
16. Kenny AM, Boxer R, Walsh S, Hager WD, Raisz LG (2006). Femoral bone mineral density in patients with heart failure. Osteoporos Int 17, 420-427.
17. Kenny AM, Prestwood KM, Biskup B, Robbins B, Zayas E, Kleppinger A et al. (2004). Comparison of the effects of calcium loading with calcium citrate or calcium carbonate on bone turnover in postmenopausal women. Osteoporos Int 15, 290-294.
18. Kriegsman DM, Deeg DJ, van Eijk JT, Penninx BW, Boeke AJ (1997). Do disease specific characteristics add to the explanation of mobility limitations in patients with different chronic diseases? A study in The Netherlands. J Epidemiol Comm Health 51, 676-685.
19. Lee AH, Mull RL, Keenan GF, Callegari PE, Dalinka MK, Eisen HJ et al. (1994). Osteoporosis and bone morbidity in cardiac transplant recipients. Am J Med 96, 35-41.
20. Malabanan A, Veronikis IE, Holick MF (1998). Redefining vitamin D insufficiency. Lancet 351, 805-806.
21. Muchmore JS, Cooper DK, Ye Y, Schlegel V, Pribil A, Zuhdi N (1992). Prevention of loss of vertebral bone density in heart transplant patients. J Heart Lung Transplant 11, 959-963.
22. Nishio K, Mukae S, Aoki S, Itoh S, Konno N, Ozawa K et al. (2003). Congestive heart failure is associated with the rate of bone loss. J Int Med 253, 439-446.
23. Ooms ME, Roos JC, Bezemer PD, van der Vijgh WJ, Bouter LM, Lips P (1995). Prevention of bone loss by vitamin D supplementation in elderly women: A randomized double-blind trial. J Clin Endocrinol Metab 80, 1052-1058.
24. Panis B, Vermeer C, van Kroonenburgh MJ, Nieman FH, Menheere PP, Spaapen LJ et al. (2006). Effect of calcium, vitamin K(1) and D(3) on bone in galactosemia. Bone 39, 1123-1129.
25. Peacock M, Liu G, Carey M, McClintock R, Ambrosius W, Hui S et al. (2000). Effect of calcium or 25OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60. J Clin Endocrinol Metab 85, 3011-3019.
26. Prince RL, Devine A, Dhaliwal SS, Dick IM (2006). Effects of calcium supplementation on clinical fracture and bone structure: Results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch Intern Med 166, 869-875.
27. Rodino MA, Shane E (1998). Osteoporosis after organ transplantation. Am J Med 104, 459-469.
28. Schleithoff SS, Zittermann A, Stuttgen B, Tenderich G, Berthold HK, Körfer R et al. (2003). Low serum levels of intact osteocalcin in patients with congestive heart failure. J Bone Miner Metab 21, 247-252.
29. Shane E, Mancini D, Aaronson K, Silverberg SJ, Seibel MJ, Addesso V et al. (1997). Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med 103 197-207.
30. Standing committee on the scientific evaluation of dietary reference intakes, Food and Nutrition Board, Institute of Medicine (1997). Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. National Academy Press: Washington DC, 250-287.
31. Steingrimsdottir L, Gunnarsson O, Indriason OS, Franzon L, Sigurdsson G (2005). Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA 294, 2336-2341.
32. Szulc P, Chapuy MC, Meunier PJ, Delmas PD (1993). Serum under-carboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 91, 1769-1774.
33. Thiebaud D, Krieg MA, Gillard-Berguer D, Jacquet AF, Goy JJ, Burckhardt P (1996). Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantation. Eur J Clin Invest 26, 549-555.
34. Van Cleemput J, DaenenW, Nijs J, Geusens P, Dequeker J, Vanhaecke J (1995). Timing and quantification of bone loss in cardiac transplant recipients. Transplant Int 8, 196-200.
35. Zittermann A, Scheld K, Stehle P (1998). Seasonal variations in vitamin D status and calcium absorption do not influence bone turnover in young women. Eur J Clin Nutr 52, 501-506.
36. Zittermann A, Schwarz I, Scheld K, Sudhop T, Berthold HK, von Bergmann K et al. (2000). Physiologic fluctuations of serum estradiol levels influence biochemical markers of bone resorption in young women. J Clin Endocrinol Metab 85, 95-101.